Pergolini M S
Department of Medical Clinics and Therapy, I Faculty of Medicine and Surgery, University Sapienza, Rome, Italy.
Clin Ter. 2009;160(2):151-7.
Hypertension is an exceedingly common disorder in Western societies; but, thanks to improved management of chronic hypertension, the number of patients who present with hypertensive crisis (HC) is less than 1%. However, critical elevation of blood pressure (BP) obliges to a proper and immediate management in order to prevent serious injury to organ target of hypertension (brain, heart, kidney and vessels). Moreover, the so called hypertensive emergencies (HE) and the hypertensive urgencies (HU) expect a several therapeutic approach. The HE warrant both prompt admission to an intensive care unit, where it is available a continuous monitoring of BP, and a prompt starting of a therapy with parenteral anti-hypertensive drugs. The treatment of HU can be managed choosing oral anti-hypertensive agents followed by a tight observation of the patient also in ambulatory system, lowering the BP more gradually over 12 to 24-48 hours. The present clinical review is aimed at reporting the current opinions on the management of HC, examining as well the drugs of largest use. Any drug that lowers BP precipitously should be avoided. Choice of the appropriate agent should be based on the underlying pathophysiological and clinical findings, on the mechanism of action, and on its potential side effects.
高血压在西方社会是一种极为常见的疾病;但是,由于慢性高血压管理的改善,出现高血压危象(HC)的患者数量不到1%。然而,血压(BP)的严重升高需要进行适当且即时的处理,以防止高血压的靶器官(脑、心脏、肾脏和血管)受到严重损伤。此外,所谓的高血压急症(HE)和高血压亚急症(HU)需要采取不同的治疗方法。HE既需要迅速入住重症监护病房,以便持续监测血压,又需要迅速开始使用胃肠外抗高血压药物进行治疗。HU的治疗可以选择口服抗高血压药物,随后在门诊系统中对患者进行密切观察,在12至24 - 48小时内更缓慢地降低血压。本临床综述旨在报告关于HC管理的当前观点,并审视使用最广泛的药物。应避免使用任何会急剧降低血压的药物。合适药物的选择应基于潜在的病理生理和临床发现、作用机制及其潜在的副作用。